Followers | 145 |
Posts | 27727 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, September 22, 2005 8:10:24 AM
Thursday September 22, 8:00 am ET
YOKNEAM, ISRAEL--(MARKET WIRE)--Sep 22, 2005 -- Syneron Medical Ltd. (NasdaqNM:ELOS - News), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, announced today that Shimon Eckhouse, the Company's Chairman, will participate in the UBS Global Life Sciences Conference on Thursday, September 29, 2005 in New York City. Syneron is scheduled to present at 9:30 a.m. E.T.
The presentation will be broadcast live over the Internet and can be accessed through the investor section on the Syneron's Web site at www.syneron.com or directly on http://event.streamx.us/event/20050926. Please go to the Web site a few minutes early, as it may be necessary to download audio software to hear the presentation. An archived replay of the presentation will also be available approximately one hour following the live presentation.
About Syneron
Syneron Medical Ltd. (NasdaqNM:ELOS - News) manufactures and distributes medical aesthetic devices that are powered by elos, the combined-energy technology of bi-polar radio frequency and light. The company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American Headquarters in Canada, European Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at www.syneron.com.
http://biz.yahoo.com/iw/050922/095927.html
Dubi
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM